Yingwei Chen

Title: Innovations of Yingwei Chen

Introduction

Yingwei Chen is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of five patents to his name, Chen has established himself as a key figure in the development of new medicinal compounds.

Latest Patents

Among his latest patents, Chen has developed cyanoquinoline derivatives, which include a compound of formula I, along with its stereoisomers, cis-trans isomers, tautomers, and pharmaceutically acceptable salts or prodrugs. Additionally, he has patented a quinazoline derivative, specifically N-[4-(3-chloro-4-fluorophenylamino)-7-(2-methoxyethoxy) quinazolin-6-yl]-2-[1-(2-methoxyethyl)piperidin-4-ylidene]acetamide, along with its pharmaceutically acceptable salts.

Career Highlights

Yingwei Chen has worked with prominent companies in the pharmaceutical industry, including Tianjin Hemay Oncology Pharmaceutical Co., Ltd. and Tianjin Hemay Bio-tech Co., Ltd. His work in these organizations has contributed to advancements in oncology and biotechnology.

Collaborations

Throughout his career, Chen has collaborated with several professionals in his field, including Hesheng Zhang and Qingchao He. These collaborations have further enhanced his research and development efforts.

Conclusion

Yingwei Chen's innovative work and patents have made a significant impact in the pharmaceutical industry. His contributions continue to advance the development of new therapeutic compounds.